Z-1542-2018 Class III Terminated

Recalled by Ameditech Inc — San Diego, CA

FDA device recall Z-1542-2018 was initiated by Ameditech Inc on Dec 15, 2017 and is designated Class III. Reason for recall: The kit box label incorrectly identifies Phencyclidine (PCP), where it should list Tricyclic Antidepressants (TCA) as one of the 10 drug analytes included in the kit box. The recall status is terminated (terminated Feb 11, 2019). Affected quantity: 828 kits (20,700 devices).

Recall details

Product Type
Devices
Report Date
May 9, 2018
Initiation Date
Dec 15, 2017
Termination Date
Feb 11, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
828 kits (20,700 devices)

Product description

Alere iScreen Dx Urine Drug Screen Card

Reason for recall

The kit box label incorrectly identifies Phencyclidine (PCP), where it should list Tricyclic Antidepressants (TCA) as one of the 10 drug analytes included in the kit box.

Distribution pattern

Distributed domestically to AZ, FL, IL, ND, NV, PA, TN, TX, VA.

Code information

Part No. X11-IS10-Dx, Lot No. 173351, 173686, 174055, 176002.

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1542-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1542-2018. Report a data issue: hello@regdatalab.com.